Kikaku America International

Kikaku America International
Kikaku America International is healthcare communications company that was founded in 1986 by Michael R. Sonnenreich and Masahiro Yamagata. Along with its unique network of legal, medical and business representatives and consultants, Kikaku provides its clients with creative advertising and promotional services. With its American expertise and its understanding of the needs of Japanese pharmaceutical companies, Kikaku offers a unique service tailored to the needs of International and Japanese pharmaceutical companies, focusing on the specialized planning required by pharmaceutical, diagnostics, and device manufacturers to ensure the success of those preparing to enter the United States marketplace, and those who are currently doing business in the United States marketplace and globally.
Search Engine Marketing Research
Kikaku provides many of its pharmaceutical clients over the years with search engine marketing research through its NETsendex service. Kikaku's NETsendex research pinpoints a companies search engine opportunity and helps to dramatically increase qualified traffic to a web site. Kikaku also provides Search Engine Optimization services as well.
Kikaku Publications
Kikaku America International publishes annual reports each year such as the 2008 Senior Care Digest Interdisciplinary Report: A Survey of Long-Term Care Health Professionals, an annual report of long-term care leaders, including medical directors, consultant pharmacists, directors of nursing (DONs), and nurse practitioners. The report, which is part of the sanofi-aventis Managed Care Digest Series®, focuses on current issues such as the impact of Medicare Part D implementation, changes to the Nursing Facility Surveyor Guidelines, and interactions between the various disciplines.
Another report Kikaku publishes is the Biologics Trend Report Sponsored By UCB, Volume 1. In this report, various industry stakeholders share their perspectives on the management and delivery of biologic treatments for Crohn's disease and rheumatoid arthritis. Managed care organizations, PBMs and specialty pharmacy providers, gastroenterologists, rheumatologists, and physicians’ reimbursement specialists participated in the research. They provided feedback on how they are managing these drugs in order to provide the best clinical outcomes while also achieving cost efficiencies and what some of the issues are that they must contend with throughout the process. The report is intended to help foster a collaborative approach in achieving practical, integrated solutions to the management of biologic therapies.
Kikaku has produced the Galderma Quality Report for Dermatology & Managed Care, Vol. II. This report is one of the first resources to take a major inside look at the practice of dermatology within managed care. One will learn how and why dermatology is being managed by health care companies and what are the latest trends. The report is a national survey about current coverage, reimbursement policies, referral policies and other key issues. It provides managed care decision-makers with critical information on how managed care organizations throughout the country deal with dermatology issues such as formulary, copayment, billing and reimbursement issues.
Kikaku has worked with Teva Neuroscience and the National Multiple Sclerosis Society to create The Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers, and Patients. National Multiple Sclerosis Society—in conjunction with a group of managed healthcare professionals, physicians, and academicians—researched current issues in the care of multiple sclerosis patients in order to assess trends in the management of MS. The participants in this research were managed care organizations (MCOs); neurologists; those responsible for reimbursement, billing, and coding; specialty pharmacy companies; case managers; and MS patients.

Main Menu

See Also

Main Menu